New pancreatic cancer drug carries a $39,800 monthly list price: What to know
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"New pancreatic cancer drug carries a $39,800 monthly list price: What to know" is generating significant coverage in the Business category, with 1 articles from 1 distinct sources tracked by PULSE so far.
Outlets currently covering the story include BioPharma Dive. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 80d ago.
Quick answers
Why is "New pancreatic cancer drug carries a $39,800 monthly list price: What to know" trending?
Because 1 independent news sources published 1 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (2)
- Opinion | Trump’s cuts threaten access to a life-saving pancreatic cancer drug MS NOW · 81d ago
- Revolution pancreatic cancer drug should quickly become a blockbuster, analysts say BioPharma Dive · 81d ago
Topics
Related trends
Nvidia's first post-Jensen earnings and Anthropic's IPO: What to watch this week
Nvidia reports earnings Tuesday and Anthropic lists Thursday as tech stocks slide on leadership crisis and AI bubble fears.
‘Star Wars: A New Hope’ Set For IMAX 70mm Re-Release
Lucasfilm plans to unveil its future Star Wars movie slate at Star Wars Celebration in London next April, ending a theatrical drought since 2019's The Rise of Skywalker.
‘Y&R’s New Head Writers Promise ‘Sexy’ Next Chapter and Cast Surprises
New head writers for 'The Young and the Restless' preview explosive shifts, a sexy next chapter, and major cast surprises.
Treasury Rally Gets New Boost as Election Hammers the AI Trade
Treasury markets rally as a U.S. stock selloff and midterm election results impact investor focus.
What they're saying after Michigan's loss to MSU: Kyle Whittingham, staff 'in over their heads'
Michigan State's rivalry victory over Michigan triggers intense scrutiny of Kyle Whittingham's tenure as Wolverines head coach across 14 articles from eight outlets.
“What Are We Doing Here?”: Blazers Announcers Call Out Victor Wembanyama for Abusing NBA Loophole
Portland announcers sharply criticized Victor Wembanyama for utilizing an NBA rule loophole during a lopsided loss to the Spurs.